While tau-seeding activities represented by the average ThT fluorescence intensities were significantly higher in AD samples versus non-AD samples, small numbers of false negative cases in the AD sample groups (or end-point overlapping between AD and non-AD in the amplified fluorescent signals) were also observed (Figures 3, 4). The gene discussed is MAPT; the disease is Alzheimer disease.